Merit Medical Systems Cash on Hand 2010-2024 | MMSI

Merit Medical Systems cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Merit Medical Systems cash on hand for the quarter ending June 30, 2024 was $0.637B, a 783.22% increase year-over-year.
  • Merit Medical Systems cash on hand for 2023 was $0.587B, a 905.06% increase from 2022.
  • Merit Medical Systems cash on hand for 2022 was $0.058B, a 13.79% decline from 2021.
  • Merit Medical Systems cash on hand for 2021 was $0.068B, a 19.04% increase from 2020.
Merit Medical Systems Annual Cash on Hand
(Millions of US $)
2023 $587
2022 $58
2021 $68
2020 $57
2019 $44
2018 $67
2017 $32
2016 $19
2015 $4
2014 $7
2013 $7
2012 $10
2011 $10
2010 $4
2009 $6
Merit Medical Systems Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $637
2024-03-31 $582
2023-12-31 $587
2023-09-30 $59
2023-06-30 $72
2023-03-31 $58
2022-12-31 $58
2022-09-30 $51
2022-06-30 $63
2022-03-31 $54
2021-12-31 $68
2021-09-30 $69
2021-06-30 $70
2021-03-31 $59
2020-12-31 $57
2020-09-30 $45
2020-06-30 $50
2020-03-31 $50
2019-12-31 $44
2019-09-30 $37
2019-06-30 $35
2019-03-31 $50
2018-12-31 $67
2018-09-30 $52
2018-06-30 $44
2018-03-31 $34
2017-12-31 $32
2017-09-30 $23
2017-06-30 $38
2017-03-31 $26
2016-12-31 $19
2016-09-30 $17
2016-06-30 $10
2016-03-31 $5
2015-12-31 $4
2015-09-30 $6
2015-06-30 $12
2015-03-31 $10
2014-12-31 $7
2014-09-30 $6
2014-06-30 $9
2014-03-31 $13
2013-12-31 $7
2013-09-30 $9
2013-06-30 $13
2013-03-31 $9
2012-12-31 $10
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $10
2011-09-30 $6
2011-06-30 $63
2011-03-31 $3
2010-12-31 $4
2010-09-30 $5
2010-06-30 $4
2010-03-31 $6
2009-12-31 $6
2009-09-30 $6
2009-06-30 $5
2009-03-31 $16
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.622B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.251B 18.22
McKesson (MCK) United States $65.379B 17.99
Cardinal Health (CAH) United States $27.255B 14.96
West Pharmaceutical Services (WST) United States $21.562B 42.04
Cooper (COO) United States $21.228B 30.22
Labcorp (LH) United States $18.800B 15.66
Align Technology (ALGN) United States $16.519B 31.91
Henry Schein (HSIC) United States $8.719B 15.97
DENTSPLY SIRONA (XRAY) United States $5.179B 13.89
CONMED (CNMD) United States $2.287B 19.88
Patterson (PDCO) United States $1.825B 9.63
STAAR Surgical (STAA) United States $1.531B 69.16
Lifevantage (LFVN) United States $0.122B 16.84
Pro-Dex (PDEX) United States $0.080B 37.55